Todd Lehman Joins LumaBridge as Vice President and Head of Business De...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: October 4, 2023

Get a Free Google Pixel 8 and Unleash its Full 5G Potential Only at T-Mobile, America’s 5G Leader • Global Clean Energy Reports Largest Camelina Acreage Worldwide • NAREB's 60-CITY, BLACK WEALTH TOUR BEGINS IN HOUSTON WITH A COMMUNITY WEALTH BUILDING DAY • CAMS Wins Ragan CSR, ESG and Diversity Awards • MERGE Acquires Zee Jay Digital to Orchestrate the Content Supply Chain for Superior CX • Six wheelchair tennis players nominated to Santiago 2023 Canadian Parapan Am Team • ACE Cash Express Supports Homes For Our Troops to Help Veterans Rebuild Their Lives • Cartamundi and Warner Bros. Discovery Global Consumer Products Unveil the DC “Selfie Moments” Limited-Edition Hybrid • KIA AMERICA HONORS SEASON 18 WINNER OF "AMERICA'S GOT TALENT" • Patrick and Brittany Mahomes’ 15 and the Mahomies Foundation Establishes National Partnership With Boys & Girls Clubs • Avangrid Schedules Third Quarter 2023 Earnings Release and Conference Call • Statement - Ministers Anandasangaree, Vandal, Hajdu, and Ien issue a statement of support on Sisters in Spirit Day and the Natio • Vancouver International Airport Selects LAT Multilingual to Engage with Chinese Travellers • Grupo EULEN announces Angeles Campoy as the New Chief Executive Officer for USA • Investments and Innovations Drive Expansion of Europe's Elderly Care Medical Devices Market • Qwoted Launches Free Networking Tools for PR Industry • FINRA Foundation Awards 2023 Ketchum Prize to Long-Time Financial Fraud Fighter Doug Shadel • Illume Fertility Founder and Medical Director, Dr. Mark Leondires, Co-Authors the First All-Inclusive Guide to Donor Conception • Consumers Energy Continues Clean Energy Transition with Plans for Solar Project at Former Coal Plant Location • Indie Beauty and Wellness Brand LĀ SOL Collective Expands Product Line with HYDRATE Body Oil

Todd Lehman Joins LumaBridge as Vice President and Head of Business Development

SAN ANTONIO , May 31 /Businesswire/ - LumaBridge, a clinical research organization (CRO) dedicated to discovering, developing, and testing emerging biotechnologies related to cancer therapies, today announced the appointment of Todd Lehman as Vice President and Head of Business Development.

Todd brings nearly 20 years of client services, commercial and clinical operations experience to LumaBridge. His expertise spans multiple therapeutic areas, with a particular emphasis on oncology and ophthalmology. Prior to joining LumaBridge, Todd held various leadership roles in operations and portfolio management with a focus on the biotech customer at PPD, a Thermo Fisher Scientific company. Prior to PPD, he led the Medical Affairs, Global Clinical & Regulatory Operations at Alcon Laboratories. Todd began his career in the clinical research industry in 2004 at Rx Development Resources, the CRO division of Sirion Therapeutics. Todd holds an M.S. in biomedical engineering and a B.S. in chemical engineering, from the University of South Florida.

"We are thrilled to welcome Todd to the LumaBridge team," said David Boyle, Chief Executive Officer of LumaBridge. "Todd's extensive experience in the industry will play a pivotal role in driving our next phase of growth as we continue to scale our clinical trial capabilities."

“I’m honored to be joining LumaBridge at this exciting stage of growth in the company’s evolution,” said Todd Lehman. “I look forward to supporting the continued efforts of our customers in bringing innovative solutions to oncology patients.”

About LumaBridge

LumaBridge is a specialty clinical research organization (CRO) focused on creating innovative clinical trial solutions for biopharma companies. Founded in 2014 as Cancer Insight, the company offers customized clinical trial guidance, strategic partnership, and personalized attention to each sponsor, accelerating the development of potential therapies.

LumaBridge builds on the success and experience of a seasoned team, led by Dr. George Peoples, to support drug development, accelerating therapies to patients and guiding biopharma companies through clinical and regulatory pathways. As part of their comprehensive CRO services, LumaBridge offers consultation on trial design and clinical development strategy.

For more information, visit lumabridge.com.